AR and prostate carcinoma: Prostate cancer (PCa) is a clinically diverse disease, varying from “insignificant cancers” to “poor-prognosis cancers” that can metastasize and lead to death.[15] Androgens stimulate prostate cancer growth, and treatments often involve reducing androgen activity through chemical or surgical castration or using antiandrogens to block androgen binding to the AR.